Ying-Hua Sun is an attorney in the Intellectual Property Practice Group in the firm's Washington, D.C. office. She manages domestic and international patent portfolios on a wide range of technologies. Fluent in Mandarin and Cantonese, Ms. Sun frequently represents and counsels Asian Pacific clients on intellectual property, corporate and privacy matters. Prior to law practice, Ms. Sun was a research associate at Beth Israel Deaconess Medical Center and worked on pre-clinical developments of novel HIV vaccines. In addition to vaccine research, Ms. Sun also published work on nuclear transport of viral macromolecules.
Ying-Hua Sun's practice areas include patent prosecution in life sciences (including organic chemistry, biochemistry, pharmacology, molecular biology, immunology, vaccines, cell biology, genetic engineering, virology, and botany) as well as in electronic and mechanical arts. Ms. Sun has experiences drafting U.S. and international patent applications from English and Chinese technical specifications for solo inventors, start-ups, universities, mid-sized and multinational companies. Ms. Sun has also opined on infringement and freedom to operate (FTO) issues.